We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Erlotinib sensitivity of MAPK1p.D321N mutation in head and neck squamous cell carcinoma.
- Authors
Ngan, Hoi-Lam; Poon, Peony Hiu Yan; Su, Yu-Xiong; Chan, Jason Ying Kuen; Lo, Kwok-Wai; Yeung, Chun Kit; Liu, Yuchen; Wong, Eileen; Li, Hui; Lau, Chin Wang; Piao, Wenying; Lui, Vivian Wai Yan
- Abstract
Head and neck squamous cell carcinoma (HNSCC) lacks predictive biomarkers for drug responses. By targeted sequencing, we identified two MAPK1 mutations in recurrent HNSCC, MAPK1p.D321N, and p.R135K. We previously reported an exceptional erlotinib responder with MAPK1p.E322K. Here, by in silico and drug studies, we determined functions of these two recurrence-associated MAPK1 mutations. Residues D321, R135, and E322 are in 3D proximity. MAPK1p.D321N drives marked in vivo erlotinib sensitivity, while p.R135K's effect is moderate.
- Publication
NPJ Genomic Medicine, 2020, Vol 5, Issue 1, p1
- ISSN
2056-7944
- Publication type
Article
- DOI
10.1038/s41525-020-0124-5